Literature DB >> 28580219

Defining rare diseases in China.

Yazhou Cui1, Jinxiang Han1.   

Abstract

China has the world's largest population of people with rare diseases. However, defining rare diseases remains a challenge in China. Over the past few decades, several definitions have been proposed but they have yet to be agreed to by all stakeholders. To overcome this impasse, a list of several rare diseases has recently been created. This rare disease list might be used in place of a prevalence-based definition, especially in healthcare policy-making.

Entities:  

Keywords:  China; definition; rare diseases

Year:  2017        PMID: 28580219      PMCID: PMC5451750          DOI: 10.5582/irdr.2017.01009

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  5 in total

1.  Rare diseases and legislation in China.

Authors:  Jing-Bo Wang; Jeff J Guo; Li Yang; Yan-De Zhang; Zhao-Qi Sun; Yan-Jun Zhang
Journal:  Lancet       Date:  2010-02-27       Impact factor: 79.321

2.  Study and analysis of the state of rare disease research in Shandong Province, China.

Authors:  Heng Zhao; Yazhou Cui; Xiaoyan Zhou; Jingxiang Pang; Xiumei Zhang; Shuangqing Xu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2012-11

Review 3.  Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 4.  Rare diseases research in China: Opportunities, challenges, and solutions.

Authors:  Jinxiang Han; Yazhou Cui; Xiaoyan Zhou
Journal:  Intractable Rare Dis Res       Date:  2012-02

5.  A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs.

Authors:  Yazhou Cui; Jinxiang Han
Journal:  Orphanet J Rare Dis       Date:  2015-03-07       Impact factor: 4.123

  5 in total
  6 in total

1.  Demographics, in-hospital analysis, and prevalence of 33 rare diseases with effective treatment in Shanghai.

Authors:  Xiaoshu Cai; Georgi Z Genchev; Ping He; Hui Lu; Guangjun Yu
Journal:  Orphanet J Rare Dis       Date:  2021-06-08       Impact factor: 4.123

2.  Health service security of patients with 8 certain rare diseases: evidence from China's national system for health service utilization of patients with healthcare insurance.

Authors:  Rui Min; Xiaoyan Zhang; Pengqian Fang; Biyan Wang; He Wang
Journal:  Orphanet J Rare Dis       Date:  2019-08-20       Impact factor: 4.123

3.  Analysis of economic burden and its associated factors of twenty-three rare diseases in Shanghai.

Authors:  Xiaoshu Cai; Hui Yang; Georgi Z Genchev; Hui Lu; Guangjun Yu
Journal:  Orphanet J Rare Dis       Date:  2019-10-22       Impact factor: 4.123

4.  National Rare Diseases Registry System (NRDRS): China's first nation-wide rare diseases demographic analyses.

Authors:  Jian Guo; Peng Liu; Limeng Chen; Haohan Lv; Jie Li; Weichao Yu; Kaifeng Xu; Yicheng Zhu; Zhihong Wu; Zhuang Tian; Ye Jin; Rachel Yang; Weihong Gu; Shuyang Zhang
Journal:  Orphanet J Rare Dis       Date:  2021-12-18       Impact factor: 4.123

5.  Determining the Topic Evolution and Sentiment Polarity for Albinism in a Chinese Online Health Community: Machine Learning and Social Network Analysis.

Authors:  Qiqing Bi; Lining Shen; Richard Evans; Zhiguo Zhang; Shimin Wang; Wei Dai; Cui Liu
Journal:  JMIR Med Inform       Date:  2020-05-29

6.  Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.

Authors:  Stéphanie Nguengang Wakap; Deborah M Lambert; Annie Olry; Charlotte Rodwell; Charlotte Gueydan; Valérie Lanneau; Daniel Murphy; Yann Le Cam; Ana Rath
Journal:  Eur J Hum Genet       Date:  2019-09-16       Impact factor: 4.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.